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Abstract 
The purpose of this study was to compare the clinical utility of PAI and MMPI-2 validity indicators 
to detect exaggeration of psychological symptoms. Participants were 49 (75.5% female) Australian 
university students who completed the MMPI-2 and PAI under one of three conditions: Control 
[i.e., honest responding (n = 20)], Feign Post Traumatic Stress Disorder [PTSD (n = 15)], or Feign 
Depression (n = 14). Participants instructed to feign depression or feign PTSD had significantly 
higher scores on the majority of MMPI-2 and PAI validity indicators compared to controls. The 
Meyers Validity Index, the Obvious-Subtle index, and the Response Bias Scale were the most 
accurate MMPI-2 validity indicators. Diagnostic-specific MMPI-2 validity indicators, such as the 
Infrequency-PSTD scales and Malingered Depression scale, were not effective at detecting 
participants instructed to feign those conditions.  For the PAI, the most accurate validity indicator 
was the MAL index; however, detection rates using this validity indicator was modest at best. The 
MMPI-2 validity indicators were clearly superior to those on the PAI at identifying feigned versus 
honest responding in this sample.  
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1.0   Introduction 
Careful evaluation of exaggeration and malingering is an essential component of every civil 
forensic psychological or psychiatric assessment. While researchers have developed a large number 
of tests to specifically evaluate poor cognitive effort [e.g., Computerized Assessment of Response 
Bias (Allen, Conder, Green, & Cox, 1997); Test of Memory Malingering (Tombaugh, 1996)], there 
are fewer published tools and methods specifically designed for detecting exaggeration of 
psychological symptoms (for exceptions see the Malingering Probability Scale (MPS; Silverton & 
Gruber, 1998), and the Structured Inventory of Malingered Symptomatology (SIMS; Smith & 
Burger, 1997). Purpose built tests for detecting malingered psychopathology, such as the SIMS, 
have received relatively little attention in the research literature, consequently the most popular 
method of detecting malingered psychopathology remains the use of indices derived from the 
Minnesota Multiphasic Personality Inventory-Second Edition [MMPI-2; (Butcher, Graham, Ben-
Porath, Tellegen, & Kaemmer, 1989)]. 
For decades, the MMPI-2 (and the original MMPI) has been one of the most commonly used 
personality inventories by psychiatrists and psychologists in clinical practice (Camara, Nathan, & 
Puente, 2000; Lees-Haley, Smith, Williams, & Dunn, 1996; Rabin, Barr, & Burton, 2005). The 
MMPI-2 is commonly used in the forensic/personal litigation setting and is well accepted as a 
valuable tool for assessing exaggeration of symptomatology in this context (Iverson & Lange, 2006; 
Lees-Haley, Iverson, Lange, Fox, & Allen, 2002). The popularity of the MMPI-2, in the context of 
personal injury litigation or disability claims, is probably at least partly due to the substantial 
growing research literature dedicated to the development and evaluation of methods of detecting 
symptom exaggeration using this inventory (for reviews see Greene, 1999; Iverson & Lange, 2006; 
Rogers, Sewell, Martin, & Vitacco, 2003). These methods now extend to the development of 
MMPI-2 diagnosis-specific validity indicators designed to detect exaggerated symptoms of 
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particular clinical conditions such as post-traumatic stress disorder (Elhai et al., 2002) and 
depression (Steffan, Clopton, & Morgan, 2003). 
The PAI (Morey, 1991), a more recently developed clinical tool for assessing psychological 
symptomatology, is a popular alternative to the MMPI-2. Because these inventories measure similar 
constructs, clinicians do not typically administer both tests and must decide which inventory to use. 
When compared to the MMPI-2, the PAI has a number of potential advantages that make this 
inventory appealing: (a) decreased administration time, (b) no item overlap on the scales, (c) items 
are answered on a 4-point Likert scale as opposed to a true/false format, and (d) ease of 
interpretation. Although the PAI has fewer validity indicators than the MMPI-2, there is a small 
body of literature supporting the use of the PAI as a tool for assessing psychological exaggeration 
(e.g., Calhoun, Earnst, Tucker, Kirby, & Beckham, 2000; Liljequist, Kinder, & Schinka, 1998; 
Rogers, Ornduff, & Sewell, 1993; Rogers, Sewell, Morey, & Ustad, 1996). 
To date, only a handful of studies have directly compared PAI and MMPI-2 validity indictors 
to detect exaggeration of psychological symptoms in the same sample. The findings from these 
studies are mixed. Some researchers have found that certain PAI validity indicators (e.g., Rogers’ 
Discriminant Function) were more effective than MMPI-2 validity scales at detecting malingering 
in 45 coached and uncoached college students instructed to feign psychiatric symptoms from 75 
psychiatric patients (Bagby, Nicholson, Bacchiochi, Ryder, & Bury, 2002). In contrast, other 
researchers have found that selected MMPI-2 validity scales (e.g., F-K, Fp, Fb, Ds-R) were more 
sensitive than PAI validity indicators in detecting 52 college students instructed to fake bad from 
432 psychiatric inpatients (Blanchard, McGrath, Pogge, & Khadivi, 2003), and 85 undergraduate 
students instructed to feign PTSD compared to clinical and non-clinical controls (Eakin, Weathers, 
Benson, Anderson, & Funderburk, 2006).  
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The purpose of this study was to evaluate and compare the MMPI-2 and PAI validity 
indicators to detect exaggeration of psychological symptoms. Using an analogue malingering 
design, this study aimed to expand on past research by (a) comparing all validity indicators from the 
PAI and MMPI-2, including a number of recently developed scales, and (b) instructing exaggerators 
to feign specific psychological problems (i.e., depression and PTSD) rather than unspecified 
psychological distress. 
2.0   Method 
2.1.   Participants 
Participants were 49 (75.5% female) undergraduate student volunteers from the subject pool of 
two metropolitan universities in Brisbane, Australia. All students who enrolled and completed the 
study received course credit for their participation. The mean age was 22.7 years (SD = 8.2).  
This sample was derived from a larger pool of 66 participants who completed the study. 
Seventeen participants were excluded because they met one or more of the following criteria: (a) 
treatment for mental health problems in the past [n = 1], (b) random response styles as indicated by 
VRIN scores of >80T on the MMPI-2 [n = 4] or ICN scores of >73T on the PAI [n = 3], (c) INF 
scores of >75T on the PAI [n = 8], and (d) were taking medication and/or receiving treatment for a 
mental health disorder [n = 5]. Exclusion criteria also consisted of TRIN scores of >80T or Cannot 
Say scores of >5 on the MMPI-2, however no one was excluded using these criteria. 
2.2. Measures 
Minnesota Multiphasic Personality Inventory-Second Edition (MMPI-2). Measures of interest 
from the MMPI-2 were (a) nine of the 10 clinical scales (all except Masculine-Feminine scale), (b) 
two PTSD-specific supplementary scales (i.e., PTSD-Keane [Pk] and PTSD-Schlenger [Ps]), (c) 10 
general validity indicators, and (d) two diagnosis-specific validity indicators. The MMPI-2 general 
validity indicators were: (i) Infrequency scale [F] (Hathaway & McKinley, 1989), (ii) F minus K 
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index [F-K] (Gough, 1947, 1950; Hathaway & McKinley, 1989), (iii) Back Infrequency Scale [Fb] 
(Hathaway & McKinley, 1989), (iv) Infrequency-Psychopathology scale [Fp] (Arbisi & Ben-Porath, 
1995), (v) Obvious minus Subtle index [O-S] (Wiener, 1948; Wiener & Harmon, 1946), (vi) 
Meyers Validity Index [MVI] (Meyers, Millis, & Volkert, 2002)], (vii) Fake Bad Scale [FBS] 
(Lees-Haley, English, & Glenn, 1991), (viii) Dissimulation Scale-Revised [Ds-R] (Gough, 1957; 
Greene, 1999), (ix) Ego Strength scale [Es] (Barron, 1956), and (x) Response Bias Scale [RBS] 
(Gervais, Ben-Porath, Wygant, & Green, 2007). The two diagnosis specific validity indicators were 
the Infrequency-Posttraumatic Stress Disorder scale [Fptsd] (Elhai et al., 2002) and the Malingered 
Depression scale [Md] (Steffan et al., 2003).  
Personality Assessment Inventory (PAI). Measures of interest from the PAI included (a) the 11 
clinical scales, (b) one PTSD-related clinical subscale (i.e., anxiety related disorders-traumatic 
stress [ARD-T]), and (c) four validity indicators. The PAI validity indicators of interest were: (i) 
NIM (Morey, 1991) (ii) MAL (Morey, 1996), (iii) RDF (Rogers et al., 1996), and (iv) CDF (Cashel, 
Rogers, & Sewell, 1995).  
2.3.   Procedure 
Participants were required to complete both the MMPI-2 and the PAI. The order of 
administration was counterbalanced such that equal numbers of participants in each condition 
completed either the PAI or the MMPI-2 first. Prior to completing both personality inventories, 
participants received written instructions for their experimental conditions, informed consent was 
obtained, and an opportunity was provided for participants to ask questions about the experiment. 
Testing was carried out in one three hour session. Participants were encouraged to take a break 
between tests if necessary.  
Participants were randomly assigned to one of three conditions: (a) Control [i.e., genuine 
responding], (b) Feign Post Traumatic Stress Disorder [PTSD], and (c) Feign Depression. Control 
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participants were given standard test instructions. Experimental group participants were given 
instructions designed to assist them to feign PTSD or depression prior to completion of the MMPI-2 
and PAI. These instructions comprised three elements: (a) reading of a case scenario that described 
the motivations for faking (see Appendix), (b) a study phase exposing participants to diagnostic 
criteria for PTSD or Major Depression that could be readily found on the internet, and (c) a test 
phase during which participants completed an eight item true/false test of information about PTSD 
or Major Depression to ensure they had sufficient understanding of the disorder about which they 
were instructed to feign. Participants who were unable to correctly answer all eight test items were 
provided with a brief one-on-one instruction regarding their incorrect responses before they were 
allowed to complete personality inventories. The mean score (maximum score = eight) on the eight 
item questionnaire was 7.8 (SD = 0.4, range = 6 to 8) for the Feign PTSD group and 7.7 (SD = 0.6, 
range = 7 to 8) for the Feign Major Depression group. In both groups, the majority of participants 
correctly answered all eight items (Feign PTSD = 85.7%; Feign Depression = 78.6%), 
demonstrating that they had sufficient understanding of the conditions they were asked to feign.  
An incentive was incorporated in this study to encourage realistic performance in each of the 
three conditions. All participants were informed they could win a cash prize of AUD $400 
depending on their performance. Control participants were informed that the prize would be 
awarded for honest responses. Participants in experimental conditions were informed that winners 
would be selected on the performance quality (i.e., the extent to which they feigned depression or 
PTSD in a believable manner) and were specifically instructed not to respond honestly. In reality, 
prize-winners were determined randomly based on a lottery system, consistent with ethical 
guidelines. 
After completion of the PAI and MMPI-2, participants received a brief post-experiment 
questionnaire designed to: (a) evaluate their understanding of the instructions, (b) rate their ability 
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to simulate PTSD or depression, and (c) document strategies used to simulate depression/PTSD. 
Prior to administration of the post-experiment questionnaire, written instructions were provided 
advising them that questionnaire responses would not be used to determine prize eligibility. This 
was considered particularly important for participants in the experimental conditions; these 
participants received explicit instructions to stop feigning and were asked to respond honestly to 
items on the post-experimental questionnaire. At the completion of testing, participants were 
debriefed using a project information sheet. 
3.0.   Results 
3.1.   Comprehension of Experimental Instructions 
For both groups of feigned responders, 100% of participants reported that they understood the 
study instructions. More than half of the participants (Feign PTSD = 57.1%, Feign Depression = 
64.3%) reported that their level of understanding of the instructions was “very good”, and 
approximately one third (35.7% both groups) reported that their level of understanding was “good”. 
The majority of the Feign Depression group rated their ability to simulate depression as “very good” 
(21.4%), “good” (35.7%), or “average” (28.6%). The majority of the Feign PTSD group rated their 
ability to simulate PTSD as “good” (50.0%) or “average” (42.9%). No one from this group reported 
that their ability to simulate PTSD was “very good”.  
3.2.   Comparison of Clinical Scales 
To explore the effect of experimental condition on the MMPI-2 and PAI scales, a series of one-
way ANOVAs were conducted using the MMPI-2 and PAI scales as dependent variables and 
experimental condition as the independent variable (i.e., Control, Feign Depression, Feign PTSD). 
Descriptive statistics, ANOVA results, and effect sizes (Cohen, 1988) for the MMPI-2 and PAI 
clinical scales, and selected MMPI-2 and PAI PTSD-specific scales, is presented in Table 1.  
< TABLE 1 ABOUT HERE > 
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The probability of Type 1 error increases when multiple statistical comparisons are made, so 
the reader should have the most confidence in findings that are below p < .01. For the MMPI-2, 
there were significant main effects on all scales (all p <.001), with the exception of the Ma scale (p 
= .375). Post hoc comparisons revealed that participants in the Feign Depression and Feign PTSD 
group had consistently higher scores on the Hs, D, Hy, Pd, Pa, Pt, Sc, Si, Pk, and Ps scales 
compared to the Control group (all p < .001; Effect size range: d = 1.50 to d = 6.11, very large 
effect sizes). There were no differences on the majority of clinical scales or on the two PTSD-
specific supplementary scales (i.e., Pk and Ps) between the Feign Depression and Feign PTSD 
group, with the exception of the Pd and Si clinical scales in which the Feign Depression group 
scored higher than the Feign PTSD group (d = .98 and d = 1.05 respectively, large effect sizes).  
For the PAI, there were significant main effects on the ARD-T subscale and seven of the 11 
clinical scales (all p <.001), with the exception of MAN, ANT, ALC, and DRG (p = .147 to p = 
.740). Post hoc comparisons revealed that participants in the Feign Depression and Feign PTSD 
group had consistently higher scores on the SOM, ANX, ARD, DEP, PAR, SCZ, BOR scales 
compared to the Control group (all p < .001; effect size range: d = 1.85 to d = 6.31, very large effect 
sizes). For the DEP and PAR scales, the Feign Depression group scored higher than the Feign 
PTSD group (d = 1.54 and d = .86 respectively, large effect sizes). For the ARD scale and ARD-T 
subscale, the Feign PTSD group scored higher than the Feign Depression group (p <.001, d = 1.00 
and d = 1.01 respectively, large effect size).  
3.3.   Comparison of Validity Indicators 
To explore the effect of experimental condition on the validity indicators of the MMPI-2 and 
PAI, a series of one-way ANOVAs were conducted using the MMPI-2 and PAI validity indicators 
as dependent variables, and experimental condition as the independent variable (i.e., Control, Feign 
Depression, Feign PTSD). Descriptive statistics, ANOVA results, and effect sizes (Cohen, 1988) for 
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the MMPI-2 and PAI general validity indicators, and MMPI-2 diagnosis-specific validity indicators, 
stratified by group is presented in Table 2.  
< TABLE 2 ABOUT HERE > 
For the MMPI-2, there were significant main effects on all 10 general validity indicators (all 
<.001), but not on the two diagnosis-specific validity indicators (Fpstd, p = .674; Md, p = .891). 
Post hoc comparisons revealed that, compared to controls, participants in the Feign Depression and 
Feign PTSD group had consistently higher scores on eight of the 10 general validity indicators (F, 
Fb, Fp, FBS, Ds-R, O-S, MVI, and RBS; all p <.001; Cohen’s d = 1.61 to d = 4.44, very large effect 
sizes), and consistently lower scores on Es (p <.001, d = 2.84 to d = 3.11, very large effect sizes). 
While the Feign PTSD and Feign Depression groups also had higher scores on F-K compared to the 
Control group (p <.001, d = 2.85 and 2.70 respectively, very large effect sizes), significantly higher 
scores on F-K scale were found in the Feign Depression group compared to the Feign PTSD group 
(p <.05, d = .71, medium effect). When comparing all validity indicators, the largest effect sizes 
were for RBS (Controls vs. Feign Depression [d = 4.44] and Feign PTSD [d = 3.17]), MVI 
(Controls vs. Feign Depression [d = 3.18] and Feign PTSD [d = 3.74]), and the F scale (Controls vs. 
Feign Depression [d = 3.93] and Feign PTSD [d = 3.21]).  
For the PAI, there were significant main effects on all the validity indictors (all p <.001), with 
the exception of CDF (p = .761). Post hoc comparisons revealed that participants in the Feign 
Depression and Feign PTSD group had consistently higher scores on the NIM and MAL scales 
compared to the Control group (all p< .001; Effect size range: d = 1.73 to d = 2.28, very large effect 
sizes). For RDF, the Feign Depression group scored higher on this scale compared to the Feign 
PTSD and Control group (p <.001, d = 1.61 and d = 1.00 respectively, large effect sizes) but there 
were no significant differences between the Control group and the Feign PTSD group on this scale 
(p >.05). The largest effect sizes were for NIM (Controls vs. Feign Depression [d = 2.28] and Feign 
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PTSD [d = 1.74]) and MAL (Controls vs. Feign Depression [d = 2.23] and Feign PTSD [d = 1.73]).  
3.4.   Detection of Feigned Responding: Depression vs. PTSD 
To compare the effectiveness of PAI and MMPI-2 general validity indicators and diagnosis-
specific validity indicators to identify participants instructed to Feign Depression versus Feigned 
PTSD from genuine responding, results from a clinical outcomes analysis using test-operating 
characteristics are presented in Table 3 (i.e., MMPI-2) and Table 4 (i.e., PAI). These tables present 
the sensitivity, specificity, positive predictive power (PPP), and negative predictive power (NPP) 
values of the MMPI-2 general and diagnosis-specific validity indicators and PAI validity indicators 
to identify feigned responding, by group, using various cutoff scores. Because the calculation of 
PPP and NPP is influenced by the base rate of the condition/behaviour under consideration, PPP 
and NPP values were calculated using a hypothetical base rates of 30% for comparative purposes 
[for a further discussion of the necessity to calculate PPP and NPP values for hypothetical base 
rates, see (Curtis, Greve, Bianchini, & Brennan, 2006; Greve, Bianchini, Love, Brennan, & Heinly, 
2006; Heinly, Greve, Bianchini, Love, & Brennan, 2005; Slick, 2006)]. For the majority of 
measures, more than one cutoff score was evaluated due to the lack of consensus in the literature 
regarding which cutoff scores are most effective, even for well established indexes (e.g., F, Fb, Fp, 
FBS). For some of the more recently developed indexes (e.g., MVI, RBS, Md), a range of cutoff 
scores above and below the recommended cutoff score was evaluated. However, only selected 
cutoff scores are presented combined with the recommended cutoff score.    
<TABLES 3 & 4 ABOUT HERE> 
Optimal cut-off scores were identified on each scale by an examination of sensitivity, 
specificity, and predictive power values in each group separately. The selection of optimal cut-off 
scores was biased towards the correct identification of malingering (i.e., PPP ≥ .90). For the MMPI-
2 validity indicators, optimal cutoff scores for both groups were as follows: (a) O-S ≥ 100T, (b) Es 
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≤ 30T, (c) Ds-R ≥ 90T, (d) FBS ≥ 25, (e) F-K ≥ 10, (f) Fb ≥ 110T, (g) Fp ≥ 90T, (h) F ≥ 90T, (i) 
RBS ≥ 9, and (j) MVI ≥ 4. The one exception was the MMPI-2 RBS scale for the Feign Depression 
group, whereby a higher cutoff score of ≥12 was considered optimal. For the PAI validity 
indicators, optimal cutoff scores for both groups were as follows: (a) NIM ≥ 80T, (b) MAL ≥ 3, and 
(c) RDF ≥ 1.80. Comparison of the overall ability of the MMPI-2 general validity indicators to 
detect Feigned Depression versus Feigned PTSD revealed comparable specificity, PPP, and NPP 
between experimental conditions (i.e., Specificity: Feign Depression = .90 to 1.0, Feign PTSD = .90 
to 1.0; PPP: Feign Depression = .81 to 1.0, Feign PTSD = .80 to 1.0; NPP: Feign Depression = .84 
to 1.0, Feign PTSD = .81 to 1.0). However, sensitivity values of the validity indicators varied across 
groups. The validity indicators with the greatest variation in sensitivity values were the O-S index 
(absolute difference between Feign Depression and Feign PTSD sensitivity values = .29), MVI (diff 
= .14), F scale (diff = .13), Fp (diff = .10), FBS (diff = .10) and Ds-R (diff = .10). For these validity 
indicators, higher sensitivity values were found in the Feign Depression group when using MVI, F, 
Fp, and Ds-R, and in the Feign PTSD group when using O-S and FBS.  
Comparison of the overall ability of the PAI validity indicators to detect Feigned Depression 
versus Feigned PTSD also revealed similar overall specificity, PPP, and NPP values between 
groups when compared to the MMPI-2 general validity indicators (Specificity: Feign Depression = 
.55 to 1.0, Feign PTSD = .55 to 1.0; PPP: Feign Depression = .21 to 1.0, Feign PTSD = .31 to 1.0; 
NPP: Feign Depression = .64 to .87, Feign PTSD = .83 to .71). However, sensitivity values of the 
validity indicators again varied. The validity indicators with the greatest variation were the NIM 
scale (absolute difference between Feigned Depression and Feigned PTSD sensitivity values = .31), 
RDF (diff = .22), and CDF (diff = .18). For these validity indicators, higher sensitivity values were 
found in the Feign Depression group when using NIM and RDF, but higher values were found in 
the feign PTSD group when using CDF.  
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Findings for diagnosis-specific MMPI-2 validity indicators revealed that the Fptsd scale failed 
to adequately detect participants instructed to feign feigned PTSD using any of the three cutoff 
scores (e.g., Fpstd ≥ 90T: sensitivity = .33, specificity = .70, PPP = .32, NPP = .71). Similarly, the 
Md scale failed to adequately detect participants instructed to feign Depression using the 
recommended cutoff score or any other cutoff score examined (e.g., > 22: sensitivity = .57, 
specificity = .55, PPP [30% base rate] = .35, NPP [30% base rate] = .75).  
4.0   Discussion 
There are several important findings of this study. First, with few exceptions, all of the MMPI-
2 validity indicators were superior at detecting feigned responding than any of the PAI validity 
indicators. While all PAI and MMPI-2 validity indicators showed high specificity, PPP, and NPP 
values, it was the sensitivity values that differentiated the effectiveness of the validity indicators; a 
finding consistent with previous research (Blanchard et al., 2003). In this study, sensitivity refers to 
the true positive rate of the validity indicators to detect feigned responders. While high PPP, NPP, 
and specificity values are very desirable and enable the clinician to have great confidence that a 
patient is exaggerating symptoms when detected by a certain validity indicator, a validity indicator 
with low sensitivity will only be successful in detecting a small percentage of all patients who are 
actually exaggerating symptoms and is therefore of limited clinical use. As such, the most effective 
validity indicators are those with high sensitivity values, together with high PPP, NPP, and 
specificity values. At first glance the most effective validity indicators appear to be the MMPI-2 
RBS, O-S, and MVI validity indicators, and the PAI NIM and MAL validity scales. These 
indicators all have high specificity, PPP and NPP. However, when consideration is given to the 
sensitivity of these measures, only the MMPI-2 validity indicators demonstrated adequate 
sensitivity (i.e., for use in clinical settings).  
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These results are consistent with previous research which has found that the MMPI-2 was 
superior in detection of feigned responding compared to the PAI (Blanchard et al., 2003; Eakin et 
al., 2006). Eakin and colleagues speculated that the superior performance of the MMPI-2 compared 
to the PAI may be due to two reasons. These author’s hypothesized that (a) because the PAI items 
have higher face-validity compared to the MMPI-2, this may enable successful feigned responding 
by enhancing “the ability of coached feigners to recognize and endorse items that are associated 
with the disorder being feigned” (p.153), and (b) because the response format on the MMPI-2 is 
based on a dichotomous True-False response (as opposed to the four-option likert style response 
format on the PAI), this may make it more difficult to moderate responding. Our findings are 
consistent with Eakin and colleagues’ first hypothesis; we found that individuals instructed to feign 
depression and PTSD were more successful at feigning diagnosis specific scales on the PAI (DEP, 
ARD-T) but not the MMPI-2 (i.e., D, Pk, Ps). 
The second important finding from this study is that correct classification rates of the feigned 
responders varied depending on whether participants were instructed to feign depression versus 
PTSD. Overall, a greater percentage of participants who feigned depression were correctly 
identified compared to participants feigning PTSD. While this was true for the majority of validity 
indicators on the MMPI-2 (i.e., MVI, F, Fp, and Ds-R) and PAI (i.e., NIM and RDF), the reverse 
was true for a handful of validity indicators on these tests (i.e., O-S and FBS on the MMPI-2 and 
CDF on the PAI). It is difficult to explain why these differences in rates of detection emerged 
between the two diagnostic groups. These findings are somewhat contradictory to previous research 
that has found that individuals who were instructed to feign depression were less likely to be 
detected compared to individuals instructed to feign schizophrenia on the MMPI-2 (Bagby et al., 
1997) and PAI (Rogers et al., 1993). Bagby and colleagues (1997) hypothesized that the reduced 
probably of detecting individuals feigning depression may be due to the greater likelihood that 
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individuals would be familiar, and perhaps have had experience, with depressive symptoms that 
may provide them with a “personal phenomenological template” as a basis for responding to the 
MMPI-2 items (p. 660). However, because the symptoms of schizophrenia are very different to 
those of PTSD, and there is no research to date that has compared the detection rates between 
feigned depression and PTSD, it is not possible to understand the relationship of these results to the 
current study. Further, although we were unable to identify diagnosis-specific patterns of 
responding on clinical indicators from both tests, it may be the case that rather than a general “fake 
bad” effect of our coaching, the performance of groups differed in ways yet to be identified and this 
may have impacted on classification rates. In any case, this study has clearly demonstrated that 
future research must include careful consideration of the instructional set used to induce 
malingering as instructions to fake specific disorders may result in classification statistics that do 
not generalize across psychopathologies. 
The findings from this study, and those from previous work comparing diagnostic specific 
instructions to feign responses, suggest that there may be a need for diagnosis specific validity 
indicators. However, application of two diagnosis-specific MMPI-2 validity indicators revealed no 
significant difference between (a) participants instructed to feign PTSD versus controls on the Fptsd 
scale, and (b) participants instructed to feign Depression versus Controls on the Md scale. Although 
our results failed to support this conclusion, this does not necessarily mean that diagnosis-specific 
validity indicators are not useful. Although recent research evaluating the clinical utility of the 
Fpstd and Md scales have not been promising to date (Elhai et al., 2004; Marshall & Bagby, 2006; 
Sweet, Malina, & Ecklund-Johnson, 2006), further research is required to develop and evaluate the 
usefulness of diagnostic specific validity indicators for these tests.  
The third important finding from this study is that the two new MMPI-2 scales were very 
effective at detecting exaggeration. Of the three most accurate MMPI-2 validity indicators, both of 
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the two new scales were in this group. These findings suggest that the MVI and RBS represent two 
significant advancements in MMPI-2 interpretation and detection of malingering. However, when 
compared to recommended cutoff scores for these indices (i.e., ≥5), we found that lower cutoff 
scores yielded improved accuracy. Using an MVI cutoff score of ≥4, accuracy was marginally 
improved with an increase in sensitivity compared to the recommended cutoff score, but only for 
the Feign Depression group. For the RBS, although the recommended cutoff score of ≥17 yielded 
high specificity, PPP, and NPP values, the sensitivity of this cutoff to correctly identify feigned 
responders was only moderate for both groups (i.e., feign PTSD = .47; feign depression = .71). As 
the cutoff score was decreased, the overall predictive accuracy of the measure improved. An 
optimum cutoff score of ≥9 yielded the most accurate predictive statistics in the Feign PTSD group; 
though a higher cutoff score of ≥12 was optimum for the feigned depression group. These cutoff 
scores should be viewed with some caution as the sample size used in this study was small. 
Replication of these findings in a larger group is recommended to determine the stability of the 
lower cutoff scores we identified.  
Other limitations of this study, in addition to sample size, include the use of an analogue 
malingering design and the large number of statistical comparisons we performed.  In an attempt to 
counteract these factors we: (a) employed procedures suggested to maximize the validity of 
simulation designs, and (b) have used and recommended a conservative alpha level for group 
statistics, as well as reporting effect sizes. However, these factors must still be borne in mind when 
interpreting our findings. 
In summary, this study suggests that the currently available MMPI-2 validity indicators are 
superior to the PAI validity indicators at detecting feigned responding. However, it is important to 
bear in mind that the PAI is a relatively new test (developed in 1991) when compared to the MMPI 
(originally developed in 1942 and revised in 1989). As such, there is considerably less research 
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focused on the PAI and less effort has been made to develop and refine relevant validity indicators. 
There is no reason to believe that with adequate time and research that validity indicators on the 
PAI could not be created that will match the efficacy of the current MMPI-2 scales. However, it 
remains to be seen whether the higher face-validity and the increased number of response choices 
on the PAI will lend itself to the development of equally effective validity indexes on this inventory 
when compared to the MMPI-2. In a setting in which detection of exaggerated response style is 
paramount; the MMPI-2 currently offers clinicians a particular advantage over the PAI. Our initial 
results suggest the MVI and RBS are promising tools that potentially represent a significant 
advancement in the assessment of exaggerated response style on the MMPI-2. Overall, this study 
provides important information about the relative utility of a comprehensive suite of validity 
indicators for two leading tests of psychopathology; information of particular importance to those 
clinicians who conduct civil forensic psychological evaluations. 
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Table 1.  
Descriptive statistics, ANOVA results, and effect sizes for the MMPI-2 and PAI scales by group.  
 
 Controls Feign DEP Feign PTSD   Cohen’s effect size 
 
MMPI-2 
M SD M SD M SD p Post hoc Ctrl vs. 
DEP 
Ctrl vs. 
PTSD 
DEP vs. 
PTSD 
 Hs 50.7 7.9 79.1 16.7 78.9 17.2 <.001 Ctrl < DEP & PTSD 2.47 2.37 0.01 
 D 48.3 6.9 97.8 9.8 90.3 12.8 <.001 Ctrl < DEP & PTSD 6.11 4.46 0.66 
 Hy 49.1 9.3 75.6 15.5 77.9 18.5 <.001 Ctrl < DEP & PTSD 2.23 2.18 0.14 
 Pd 55.0 10.2 83.1 13.8 71.0 11.3 <.001 Ctrl < PTSD < DEP 2.41 1.50 0.98 
 Pa 50.0 10.9 81.9 19.4 82.5 20.8 <.001 Ctrl < DEP & PTSD 2.21 2.15 0.03 
 Pt 53.8 9.8 87.0 10.0 87.1 12.0 <.001 Ctrl < DEP & PTSD 3.36 3.10 0.01 
 Sc 58.3 11.9 101.9 19.1 95.5 16.7 <.001 Ctrl < DEP & PTSD 2.93 2.67 0.36 
 Ma 56.8 10.4 53.9 11.0 52.1 7.8 .375 -- -- -- -- 
 Si 45.4 8.5 83.3 7.1 75.2 8.3 <.001 Ctrl < PTSD < DEP 4.78 3.54 1.05 
 Pk 53.4 10.4 96.7 11.3 90.3 7.9 <.001 Ctrl < DEP & PTSD 4.02 3.96 0.67 
 Ps 52.6 10.1 91.6 12.4 88.3 9.5 <.001 Ctrl < DEP & PTSD 3.53 3.63 0.30 
PAI            
 SOM 48.4 6.9 72.2 18.7 78.5 17.8 <.001 Ctrl < DEP & PTSD 2.02 2.64 0.35 
 ANX 51.7 9.7 79.1 12.5 86.7 11.9 <.001 Ctrl < DEP & PTSD 2.53 3.30 0.62 
 ARD 51.5 12.1 70.9 17.2 85.6 12.5 <.001 Ctrl < DEP < PTSD 1.37 2.78 1.00 
 DEP 51.4 10.6 106.1 5.9 91.7 12.6 <.001 Ctrl < PTSD < DEP 6.31 3.52 1.54 
 MAN 52.1 11.1 45.3 11.5 47.8 6.6 .147 -- - - - 
 PAR 49.3 7.4 82.4 18.5 69.0 12.8 <.001 Ctrl < PTSD < DEP 2.77 2.05 0.86 
 SCZ 47.7 8.8 83.3 11.9 80.5 17.1 <.001 Ctrl < DEP & PTSD 3.53 2.69 0.19 
 BOR 55.0 8.0 73.9 12.1 71.2 9.9 <.001 Ctrl < DEP & PTSD 1.95 1.85 0.25 
 ANT 57.7 12.0 54.3 14.8 55.8 10.8 .740 -- -- -- -- 
 ALC 52.7 11.2 57.7 23.1 55.7 12.3 .648 -- -- -- -- 
 DRG 52.6 10.1 60.0 23.6 53.9 11.3 .370 -- -- -- -- 
 ARD-T 56.8 15.0 81.1 16.0 92.1 6.2 <.001 Ctrl < DEP < PTSD 1.58 3.14 1.01 
N = 49; Controls (Ctrl; n = 20), Feign Depression (DEP; n = 14), Feign PTSD (PTSD; n = 15). All scores are T-scores. Cohens effect sizes = small (0.2), medium 
(0.5), large (0.8). MMPI-2 clinical scale abbreviations: Hypochondriasis (Hs), Depression (D), Hysteria (Hy), Psychopathic Deviate (Pd), Paranoia (Pa), 
Psychasthenia (Pt), Schizophrenia (Sc), Mania (Ma), Social Introversion-Extraversion (Si), PTSD-Keane (Pk), and PTSD-Schlenger (Ps). PAI clinical scale 
abbreviations: somatic complaints (SOM), anxiety (ANX), anxiety related disorders (ARD), depression (DEP), mania (MAN), paranoia (PAR), schizophrenia 
(SCZ), borderline features (BOR), antisocial features (ANT), alcohol problems (ALC), drug problems (DRG), and ARD-Traumatic Stress (ARD-T) .
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Table 2. 
Descriptive statistics, ANOVA results, and effect sizes for the MMPI-2 and PAI validity indicators by group. 
 
 Controls Feign DEP Feign PTSD   Cohen’s effect size 
 
MMPI-2 
M SD M SD M SD p Post hoc Ctrl vs. 
DEP 
Ctrl vs. 
PTSD 
DEP vs. 
PTSD 
 F 57.1 12.5 113.3 16.9 106.4 19.2 <.001  Ctrl < Dep & PTSD 3.93 3.21 0.38 
 Fb  57.4 20.6 119.4 11.5 109.3 18.3 <.001  Ctrl < Dep & PTSD 3.68 2.65 0.67 
 Fp 58.9 14.0 96.6 31.5 87.0 22.0 <.001  Ctrl < Dep & PTSD 1.78 1.61 0.36 
 F-K* -9.5 7.0 20.1 15.2 11.6 8.9 <.001 Ctrl < PTSD < Dep 2.85 2.70 0.71 
 FBS* 11.7 3.9 25.7 4.9 27.8 7.5 <.001  Ctrl < Dep & PTSD 3.25 2.96 0.34 
 Ds-R 55.0 13.5 92.7 16.9 89.3 12.9 <.001  Ctrl < Dep & PTSD 2.53 2.59 0.23 
 Es 52.2 8.8 17.4 17.2 15.1 16.1 <.001  Ctrl < Dep & PTSD 2.84 3.11 0.14 
 O-S* 11.5 62.1 205.6 91.8 187.1 53.8 <.001  Ctrl < Dep & PTSD 2.61 3.00 0.26 
 MVI 0.7 1.5 9.4 4.5 10.0 3.8 <.001  Ctrl < Dep & PTSD 3.18 3.74 0.14 
 RBS 5.2 2.2 18.1 3.9 16.4 5.3 <.001  Ctrl < Dep & PTSD 4.44 3.17 0.36 
 Fptsd 73.9 22.4 68.9 23.1 76.4 24.2 .674 -- -- -- -- 
 Md* 18.6 10.6 20.3 11.9 19.5 8.9 .891 -- -- -- -- 
PAI            
 NIM 50.5 9.1 89.3 28.4 77.3 23.8 <.001  Ctrl < Dep & PTSD 2.28 1.74 0.46 
 MAL 0.6 0.7 2.8 1.4 2.4 1.5 <.001  Ctrl < Dep & PTSD 2.23 1.73 0.28 
 RDF -0.6 1.2 1.2 1.0 0.2 1.0 <.001  Ctrl & PTSD < Dep 1.61 0.72 1.00 
 CDF 143.0 13.2 138.7 23.8 142.8 16.7 .761 -- -- -- -- 
Total N = 49; Controls (Ctrl; n = 20), Feign Depression (Dep; n = 14), Feign PTSD (PTSD; n = 15). All scores are T-scores unless otherwise indicated. *raw scores. 
Cohens effect sizes = small (0.2), medium (0.5), large (0.8). MMPI-2 validity scale abbreviations: F = Infrequency; F-K = F minus K index, Fb = Back Infrequency; 
Fp = Infrequency-Psychopathology; O-S = Obvious minus Subtle, FBS = Fake Bad Scale; Ds-R = Dissimulation Scale-Revised; Es = Ego Strength, MVI = Meyers 
et a1. (2002) Validity Index; RBS = Response Bias Scale; Fptsd = Infrequency Post-traumatic stress scale; Md = Malingered Depression scale. PAI malingering 
index abbreviations: NIM = Negative Impression Management; MAL = Malingering Index; RDF = Roger’s Discriminant Function; CDF = Cashel’s Discriminant 
Function. 
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Table 3. 
Sensitivity, specificity, and predictive power values for MMPI-2 validity indicators to detect 
feigned responding: Comparison of Feigned PTSD and Feigned Depression conditions.  
 
   Feign PTSD  Feign Depression 
 Cutoff  Sen Spec PPP 
.30 
NPP 
.30 
 Sen Spec PPP 
.30 
NPP 
.30 
General Validity Indicators 
MVI ≥4  .79 .95 .87 .91  .93 .95 .89 .97 
   ≥5a  .79 .95 .87 .91  .87 .95 .88 .94 
RBS ≥9  1.0 .95 .90 1.0  1.0 .95 .90 1.0 
 ≥12  .73 1.0 1.0 .90  1.0 1.0 1.0 1.0 
   ≥17a  .47 1.0 1.0 .81  .71 1.0 1.0 .89 
F ≥75  .87 .80 .65 .93  .93 .80 .67 .96 
 ≥90  .73 1.0 1.0 .90  .86 1.0 1.0 .94 
 ≥110  .53 1.0 1.0 .83  .64 1.0 1.0 .87 
Fp ≥75  .73 .85 .68 .88  .64 .85 .65 .85 
 ≥90  .47 1.0 1.0 .81  .57 1.0 1.0 .84 
 ≥110  .13 1.0 1.0 .73  .50 1.0 1.0 .82 
Fb ≥75  .93 .85 .73 .97  1.0 .85 .74 1.0 
 ≥90  .93 .90 .80 .97  1.0 .90 .81 1.0 
 ≥110  .53 .95 .82 .83  .86 .95 .81 .96 
F-Kb ≥1  .93 .90 .80 .97  .93 .90 .80 .97 
 ≥10  .60 1.0 1.0 .85  .64 1.0 1.0 .87 
FBSd ≥25  .67 1.0 1.0 .88  .57 1.0 1.0 .84 
 ≥30  .60 1.0 1.0 .85  .21 1.0 1.0 .75 
Ds-Rb ≥75  .87 .90 .79 .94  .86 .90 .79 .94 
 ≥90  .47 1.0 1.0 .81  .57 1.0 1.0 .84 
Esb ≤30  .80 1.0 1.0 .92  .71 1.0 1.0 .89 
 ≤20  .60 1.0 1.0 .85  .50 1.0 1.0 .82 
O-Sc ≥100  1.0 .95 .90 1.0  .71 .95 .86 .89 
 ≥150  .67 .95 .85 .87  .64 .95 .85 .86 
Diagnosis Specific Validity Indicators 
Md 20  -- -- -- --  .64 .55 .38 .78 
   22a  -- -- -- --  .57 .55 .35 .75 
 24  -- -- -- --  .57 .60 .38 .77 
 26  -- -- -- --  .50 .65 .38 .75 
 28  -- -- -- --  .43 .75 .42 .75 
Fptsd ≥75  .40 .50 .26 .66  -- -- -- -- 
 ≥90  .33 .70 .32 .71  -- -- -- -- 
 ≥110  .13 .95 .53 .72  -- -- -- -- 
N = 49 (Controls, n = 20; Feigned Depression, n = 14; Feign PTSD, n = 15). Abbreviations: F = Infrequency; F-K = F 
minus K index, Fb = Back Infrequency; Fp = Infrequency-Psychopathology; O-S = Obvious minus Subtle, FBS = Fake 
Bad Scale; Ds-R = Dissimulation Scale-Revised; Es = Ego Strength, MVI = Meyers et a1. (2002) Validity Index; RBS 
= Response Bias Scale; Fptsd = Infrequency Post-traumatic stress scale; Md = Malingered Depression scale. Sens. = 
Sensitivity; Spec. = Specificity; PPP = Positive predictive power; NPP = Negative predictive power.  
Footnotes: acutoff score recommended by original scale developers; bcutoff scores as recommended by Meyers et al. 
(2002); ccutoff scores as recommended by Greene (1999); dcutoff scores as recommended by Lees-Haley (1992)
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Table 4. 
Sensitivity, specificity, and predictive power values for PAI validity indicators to detect feigned 
responding: Comparison of Feigned PTSD and Depression groups.  
 
   Feign PTSD  Feign Depression 
 Cutoff  Sen Spec PPP 
.30 
NPP 
.30 
 Sen Spec PPP 
.30 
NPP 
.30 
NIMa ≥70  .53 .95 .82 .83  .71 .95 .86 .89 
 ≥75  .40 .95 .77 .79  .71 .95 .86 .89 
 ≥80  .33 1.0 1.0 .78  .64 1.0 1.0 .87 
 ≥85  .33 1.0 1.0 .78  .50 1.0 1.0 .82 
 ≥92  .33 1.0 1.0 .78  .43 1.0 1.0 .80 
 ≥110  .13 1.0 1.0 .73  .29 1.0 1.0 .77 
MALb ≥2  .73 .90 .76 .89  .79 .90 .77 .91 
 ≥3  .53 1.0 1.0 .83  .50 1.0 1.0 .82 
 ≥4  .13 1.0 1.0 .73  .36 1.0 1.0 .78 
 ≥5  .07 1.0 1.0 .71  .14 1.0 1.0 .73 
RDFc ≥0.124  .53 .70 .43 .78  .86 .70 .55 .92 
 ≥1.80  .07 1.0 1.0 .71  .29 1.0 1.0 .77 
 ≥0.57  .40 .80 .46 .76  .79 .80 .63 .90 
CDFd ≥148.4  .47 .55 .31 .71  .29 .55 .21 .64 
N = 49 (Controls, n = 20; Feigned Depression, n = 14; Feign PTSD, n = 15). Abbreviations: NIM = Negative 
Impression Management; MAL = Malingering Index; RDF = Roger’s Discriminant Function; CDF = Cashel’s 
Discriminant Function. Sens. = Sensitivity; Spec. = Specificity; PPP = Positive predictive power; NPP = Negative 
predictive power. Footnotes: asix cutoff scores were evaluated; two that have been previously described in the literature 
(Blanchard et al., 2003; Morey, 1991;), and four new ones included for exploratory purposes;  btwo standard cutoff 
scores were evaluated (≥3 and ≥5; Morey, 1996). Four additional cutoff scores were included for exploratory purposes 
(i.e., >1, >2, >4, and >6) but not all are included in this table; ccutoff scores as recommended by (Blanchard et al., 2003; 
Gervais et al., 2007; Morey & Lanier, 1998; Rogers et al., 1996)];  dcutoff scores as recommended by Morey and Lanier 
(1998). 
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APPENDIX 
Experimental Group Instructions 
 
Feign PTSD Case Scenario  
In this experiment, we are interested in how well people can fake symptoms of Post Traumatic 
Stress Disorder (PTSD). I want you to imagine that you have been involved in a motor vehicle 
accident. The car you were driving had a head on collision with a car that was attempting to pass a 
truck around a blind corner. You were not at fault in the accident. The accident occurred because 
the driver of the oncoming car was driving recklessly. You did not sustain a head injury and did not 
lose consciousness. You can clearly recall the details before and after the accident and also the 
impact of the collision. You sustained a number of physical injuries (i.e., 3 fractured ribs, a 
fractured left arm, and a fractured left ankle) and was transferred to hospital and admitted for 
treatment. You required orthopedic surgery for your ankle injury in which you had two stabilizing 
pins placed. You were discharged from hospital after 6 days and your physical recovery over the 
next few months was good. However, you were unable to return to work for the next 3 months and 
did not get paid during that time. In addition, you had to pay for physiotherapy treatment 2 times 
per week over this 3 month period. After 3 months you are able to return to work. After 6 months 
you were, more-or-less, fully recovered from your physical injuries. The accident did not affect 
your emotional and psychological well-being. Because the accident was not your fault, you consult 
a lawyer to seek financial compensation for loss of income and the physiotherapy treatment costs. 
You calculate that these costs are $20,000 and seek compensation for this amount. Your lawyer 
informs you that you should have no problem receiving the $20,000 based on your physical injuries. 
However, your lawyer tells you that you could receive a larger sum of money if you “pretend” to 
have Post Traumatic Stress Disorder resulting from the accident. Thinking that this is a good idea, 
you decide to take your lawyers advice and formally seek compensation not just for the financial 
loss resulting from your physical injuries (e.g., loss of income, physiotherapy bills), but also for 
“ongoing and persisting symptoms of Post Traumatic Stress Disorder” as a result of your accident. 
However, your solicitor impresses on you that it is very important to show your problems in a 
believable manner, otherwise it may become apparent that you are feigning symptoms and you 
could potentially get no financial compensation even for your physical injuries. As part of your 
compensation claim, you are referred to a psychologist for assessment. Because you want to make 
sure that you are knowledgeable and fully prepared to feign symptoms of Post Traumatic Stress 
Disorder, you search the internet and find diagnostic criteria for Post Traumatic Stress Disorder. 
These symptoms are described in the attached sheet. Prior to your assessment, you carefully study 
these symptoms. As part of your assessment, you are required to complete two personality 
inventories; the MMPI-2 and PAI. In a moment, you will be given diagnostic criteria for Post 
Traumatic Stress Disorder that was obtained from the internet. Before completing the MMPI-2 and 
PAI, you will be given 15 minutes to study this information. After the 15 minutes, you will be 
required to take a simple test to evaluate your knowledge of these symptoms. Remember, please DO 
NOT ANSWER HONESTLY to these tests. We would like you to answer the items on the MMPI-2 
and PAI by trying to fool the psychologist that you have Post Traumatic Stress Disorder. 
 
 
 
Note: For illustrative purposes, the case scenario for the PTSD experimental group is shown. The 
case scenario for the Feign-Depression group mirrors that which is presented here, with the 
exception that Depression is substituted for PTSD. 
